Risk and prognostic factors for braf mutations in papillary thyroid carcinoma

HIGHLIGHTS

• who: Thyroid Carcinoma and collaborators from the Chongqing Jiaotong University Hospital, Chongqing, China have published the research work: Risk and Prognostic Factors for BRAF Mutations in Papillary Thyroid Carcinoma, in the Journal: BioMed Research International of 18/05/2022
• what: The authors aim to investigate the risk factors that may predict the BRAFV600E mutation potential of these lesions and new prevention strategies in PTC patients. On the one hand, the purpose of this meta-analysis was to determine whether BRAFV600E mutations are associated with high-risk clinicopathological factors in PTC patients.
• how: The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.